Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific...
Reexamination Certificate
2011-03-08
2011-03-08
Gakh, Yelena G (Department: 1797)
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
C436S034000, C436S069000, C436S164000, C422S072000, C514S802000
Reexamination Certificate
active
07901694
ABSTRACT:
Methods and apparatus are disclosed for determining a new anticoagulant therapy factors for monitoring oral anticoagulant therapy to help prevent excessive bleeding or deleterious blood clots that might otherwise occur before, during or after surgery. New anticoagulant therapy factors maybe based upon the time to maximum acceleration from the time of reagent injection (TX) into a plasma sample, Embodiments include methods and apparatus for determining an anticoagulant therapy factor without requiring use of a mean normal prothrombin time determination or ISI, and may be carried out with the patient sample and a coagulation reagent.
REFERENCES:
patent: 4217107 (1980-08-01), Saito et al.
patent: 4720787 (1988-01-01), Lipscomb
patent: 5197017 (1993-03-01), Carroll et al.
patent: 5502651 (1996-03-01), Jackson et al.
patent: 5981285 (1999-11-01), Carroll et al.
patent: 6706536 (2004-03-01), Carroll et al.
Carroll Wallace E.
Jackson R. David
Bonini, Jr. Frank J.
Earley III John F. A.
Gakh Yelena G
Harding, Earley, Follmer & Frailey P.C.
Weisz David
LandOfFree
Method and apparatus for determining anticoagulant therapy... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and apparatus for determining anticoagulant therapy..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for determining anticoagulant therapy... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2770123